Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,173 | -18,495 | -14,147 | -9,491 | -4,816 |
| Depreciation Amortization | 39 | 121 | 89 | 58 | 26 |
| Accounts receivable | N/A | -11 | -40 | -11 | -11 |
| Accounts payable and accrued liabilities | -78 | 120 | 418 | 327 | 163 |
| Other Working Capital | -78 | 14 | 350 | 300 | 41 |
| Other Operating Activity | 4,910 | 12,338 | 9,034 | 5,972 | 3,003 |
| Operating Cash Flow | $-2,379 | $-5,913 | $-4,297 | $-2,846 | $-1,595 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,599 | -12,960 | -9,934 | N/A | N/A |
| PPE Investments | -60 | -265 | -223 | -247 | -110 |
| Purchase Sale Intangibles | N/A | -175 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -175 | 0 | 0 | 0 |
| Investing Cash Flow | $2,539 | $-13,400 | $-10,156 | $-247 | $-110 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 1,677 | 21,027 | 21,027 | 21,027 | 21,027 |
| End Cash Position | 1,837 | 1,714 | 6,573 | 17,934 | 19,323 |
| Net Cash Flow | $160 | $-19,313 | $-14,454 | $-3,093 | $-1,704 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,379 | -5,913 | -4,297 | -2,846 | -1,595 |
| Capital Expenditure | -60 | -265 | -223 | -247 | -110 |
| Free Cash Flow | -2,439 | -6,178 | -4,520 | -3,093 | -1,704 |